ICN PHARMACEUTICALS INC /DE/
DEFC14A, 1994-01-26
PHARMACEUTICAL PREPARATIONS
Previous: HEWLETT PACKARD CO, 11-K, 1994-01-26
Next: IDS SELECTIVE FUND INC, NSAR-B, 1994-01-26





<PAGE>
                            SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Filed by the Registrant [       ]
Filed by a Party other than the Registrant [  X  ]
 
Check the appropriate box:
[     ] Preliminary Proxy Statement
[     ] Definitive Proxy Statement
[  X  ] Definitive Additional Materials
[     ] Soliciting Material Pursuant to SS240.14a-11(c) or SS240.14a-12
 
____________________________ICN PHARMACEUTICALS, INC.___________________________
 
                (Name of Registrant as Specified In Its Charter)
 
__________________________________RAFI M. KHAN__________________________________
 
                   (Name of Person(s) Filing Proxy Statement)
 
Payment of Filing Fee (Check the appropriate box):
[     ] $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), or
14a-6(i)(2).
[     ] $500 per each party to the controversy pursuant to Exchange Act Rule
14a-6(i)(3).
[     ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and
0-11.
 
     1) Title of each class of securities to which transaction applies:
 
________________________________________________________________________________
 
     2) Aggregate number of securities to which transaction applies:
 
________________________________________________________________________________
 
     3) Per  unit  price  or  other  underlying  value  of  transaction computed
        pursuant to Exchange Act Rule 0-11.1
 
________________________________________________________________________________
 
     4) Proposed maximum aggregate value of transaction:
 
________________________________________________________________________________
 
     1 Set forth the amount on which the filing fee is calculated and state  how
it was determined.
 
[       ] Check box if any part of the fee is offset as provided by Exchange Act
          Rule  0-11(a)(2) and identify the filing  for which the offsetting fee
          was paid  previously. Identify  the  previous filing  by  registration
          statement number, or the Form or Schedule and the date of its filing.
 
1) Amount Previously Paid:
 
________________________________________________________________________________
 
2) Form, Schedule or Registration Statement No.:
 
________________________________________________________________________________
 
3) Filing Party:
 
________________________________________________________________________________
 
4) Date Filed:
 
________________________________________________________________________________
 
<PAGE>
                         FINANCIAL SCIENCES OF AMERICA
 
                               [NEWS RELEASE]
 
                  RAFI KHAN FILES $210 MILLION LAWSUIT AGAINST
                         NEW YORK TIMES CHARGING LIBEL
 
     Los  Angeles, CA. . .January 25, 1994. . .Rafi Khan, through his attorneys,
BURTON, SCOTT & ASSOCIATES, located in Melville, NY, announced today that a $210
million lawsuit has been filed  in the Supreme Court of  the State of New  York,
County  of Nassau, against The  New York Times Company,  Inc., Susan Antilla and
Sally Hoffmeister charging repeated libel.
 
     The lawsuit charges that 'The malicious and willful baseless  misstatements
by  the defendants  . . .  . .  . . were  issued at  a critical time  by them to
irreparably hurt Rafi Khan in his ICN  proxy contest and to damage his  business
reputation and income.'
 
     Commenting  on the lawsuit, Rafi Khan stated  that 'I have never, ever even
faced any charge made by  any regulatory authority in any  part of the world  at
any  time in my life, in sharp contrast  to the people who are orchestrating and
perpetrating a vicious smear campaign against me to totally damage my  business,
reputation and well being. I am left with no recourse but to take legal action.'
 
     The  lawsuit further  charges that  'All defendants  have intentionally and
maliciously interfered  with the  contractual  relations between  the  plaintiff
(Khan) and his institutional clientele.'
 
                                     # # #
 
CONTACT: Bernard L. Burton
          BURTON SCOTT & ASSOCIATES
          (516) 424-7171
 
  9255 DONENY ROAD, SUITE A  LOS ANGELES, CALIFORNIA 90069  (310) 278-4413
 



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission